Navigation Links
Oncothyreon announces March 10th webcast of fourth quarter and full year financial results conference call
Date:3/7/2008

BELLEVUE, WA, March 7 /PRNewswire-FirstCall/ - Oncothyreon Inc. (the "Company") (Nasdaq: ONTY) (TSX:ONY), a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that it intends to release its fourth quarter and full year 2007 financial results on Monday, March 10, 2008 after the close of the U.S. and Canadian markets. Following the release, Oncothyreon's management expects to discuss these financial results and give a general business update in a conference call at 4:30 p.m. EST.

The discussion is planned for a live webcast and can be accessed at http://www.oncothyreon.com. It is expected that the archive of the webcast will be available approximately one hour after completion of the discussion and will be posted on the Oncothyreon website for 30 days.

About Oncothyreon

Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit http://www.oncothyreon.com.


'/>"/>
SOURCE Oncothyreon Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Biomira announces plan to change name to Oncothyreon
2. Oncothyreon highlights corporate and clinical objectives for 2008
3. Oncothyreon to present at BIO CEO & Investor Conference
4. Oncothyreon launches new corporate website
5. Oncothyreons PX-478 is effective in preclinical model of human lung cancer
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2008)...y company to offer choice of two distinct drugs on...orms, NATICK, Mass., July 2 /PRNewswire-FirstCall...oday announced that the U.S. Food and Drug,Adminis...us-Eluting,Coronary Stent System for the treatment... private-labeled XIENCE(TM) V Everolimus-Eluting C...
(Date:7/2/2008)...ming soon to Bioniche,s growing line of injectable...REST, Ill., July 2 /- Bioniche Pharma...le pharmaceuticals, announced today,the acquisitio... line,including:, -- ENLON(R) (edrophonium chl...ON-PLUS(R) (edrophonium chloride, USP and atropine...
(Date:7/2/2008)... Northeastern University Technology Receive Fundin...logy for the Extraction of ...Allied Minds, a pre-seed investment,corporation sp...ures,Harvard University,s Office of Technology De...e creation of CryoXtract Instruments, LLC, a new,s...
(Date:7/2/2008)... potential of pre-treatment R2 levels as a possibl...y -, TORONTO, July 2 / Lor..." or the "Corporation"), a biopharmaceutical compa... pharmaceutical products and,technologies for the ...by,an Ohio State University (OSU) clinical team of...
Breaking Biology Technology:Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 2Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 3Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 4Bioniche Pharma Acquires Baxter's ENLON(R) and ENLON-PLUS(R) 2Investment Firm Allied Minds to Commercialize New Frozen Aliquotter Technology with Two Local Major Universities. 2Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 2Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 3Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 4Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 5
...Madison, Wis. If the Fusion 2006 CEO-CIO Sympos...esday and Thursday will see the Fluno Center fille... all different places but asking the same questio...o become more like one another than ever before," ... Justice and head of the Wisconsin IT Directors Co...
... Once again, some Wisconsin legislators are pushin...research restrictions that would effectively move...sin,s homegrown researchers at a competitive disad...sary regulation, state lawmakers should await guid...international -- that have recently announced sepa...
... What makes a great place to work? There are many ...eat place to work is one that inspires the passion...al hot buttons are pushed. Workers are turned on b... work in a job or an organization for more than th...aningful than a good salary and generous benefits....
...Pleasant Prairie, Wis. Now that pharmaceutical g...cres of land just across the Wisconsin state line ...hnology observers believe the impending developmen...,s existing biotech companies. , ,While Abbott has...h of its world headquarters in northern Illinois, ...
Other Biology Technology:Fusion 2006 symposium focuses on making IT work for businesses 2Federal and global guidelines on stem cell research offer a level playing field 2Federal and global guidelines on stem cell research offer a level playing field 3What makes a "best place to work"? 2What makes a "best place to work"? 3What makes a "best place to work"? 4What makes a "best place to work"? 5Abbott Labs campus in Kenosha could send ripples through local biotech 2Abbott Labs campus in Kenosha could send ripples through local biotech 3
(Date:7/3/2008)... among the ancestors of such marine creatures as c...st rise beginning 144 million years ago with no cl...l team of researchers. This contradicts previous w...on years ago and may shed light on future diversit...alogies for what is happening today from global wa...
(Date:7/3/2008)...LE, Fla. --- A farm irrigation canal would seem a ...arket parking lot. , But University of Florida s...udy with wide implications for a longstanding deba...at to amphibians, UF zoologists have found that to...om reproductive system abnormalities than toads ne...
(Date:7/3/2008)...N (2 July 2008) -- There,s little the average pers...ctricity, natural gas and other energy sources. Bu...he road and at work, we can use less energy and sa...position adopted on 20 June, says that, "Through e...an reduce energy costs; reduce the depletion of fu...
(Date:7/3/2008)...logist Marijke van Kuijk has studied the regenerat...gricultural land does regenerate to tropical fores...p nature along: pruning of foliage to free up spac... Van Kuijk used the PHOLIAGE model to calculate th... depend heavily on the products and services the f...
Breaking Biology News(10 mins):Ancient marine invertebrate diversity less explosive than thought 2Ancient marine invertebrate diversity less explosive than thought 3New study points to agriculture in frog sexual abnormalities 2New study points to agriculture in frog sexual abnormalities 3IEEE-USA position encourages energy efficiency to save households money, reduce carbon emissions 2Giving nature a helping hand 2New type of drug shrinks primary breast cancer tumors significantly in just 6 weeks 2934 1New type of drug shrinks primary breast cancer tumors significantly in just 6 weeks 2934 2ACS Systems Improving Delivery of Healthcare in Malta 17060 1ACS Systems Improving Delivery of Healthcare in Malta 17060 2ACS Systems Improving Delivery of Healthcare in Malta 17060 3Vobile Launches VideoDNA Live 3B Enables Real Time Digital Content Protection for Live Broadcast Events 2931 1Vobile Launches VideoDNA Live 3B Enables Real Time Digital Content Protection for Live Broadcast Events 2931 2Vobile Launches VideoDNA Live 3B Enables Real Time Digital Content Protection for Live Broadcast Events 2931 3International Council on Nanotechnology launches global research needs assessment 4664 1International Council on Nanotechnology launches global research needs assessment 4664 2
...worms dwelling at deep-sea hydrothermal vents opt ... degrees Fahrenheit) when given a choice of condit...f any animal studied to date. This unique preferen...rms, meal ticket, since they are apparently the on...mats of bacteria that thrive around deep-sea vents...
...measuring blood levels of specialized cells that c...he arterial lining has been discovered by Duke Uni... known as endothelial progenitor cells (EPC), are ... of arterial damage. , The researchers said that t...degree of coronary artery disease or risks for suf...
...anck Institite for Biophysical Chemistry and other...ic resonance spectroscopy (solid-state NMR) with s... potassium channels and toxins combine and change ...develop medications for high blood pressure and ma...ailure (Nature, April 13, 2006). , Our body,s cell...
...sity have taken a "snapshot" of a Velcro-like prot...the dengue virus, a linkup thought to initiate the...spread by mosquitoes, infects more than 50 million...primarily in tropical regions. , During the earli... to the "carbohydrate recognition domain," or CRD,...
Other Biology News:Some like it hot: Worms at deep-sea vents favor a fiery 45-55°C 2Measuring artery repair cells could become new heart disease test 2Measuring artery repair cells could become new heart disease test 3Unraveling the mysteries of poison 2Biologists visualize protein interaction that may initiate viral infection 2Biologists visualize protein interaction that may initiate viral infection 3
BD IMag Anti-Mouse CD90.2 (Thy1.2) Particles-MSC 2 x 109 cells
Agarose overlays are commonly used in baculovirus plaque assays. Many commercial "DNA grade" agaroses either contain contaminants that are toxic to insect cells or lack the physical characteristics r
AgarPlaque Plus Agarose 50 grams
Dithiothreitol, 1M from Upstate
Biology Products: